FDA OKs new drug to treat all forms of hepatitis C – ABC News
Washington Times |
FDA OKs new drug to treat all forms of hepatitis C
ABC News This photo provided by AbbVie shows the drug Mavyret. On Thursday, Aug. 3, 2017, the Food and Drug Administration approved Mavyret to treat all forms of hepatitis C. The drug works in as little as eight weeks and is for patients without significant … FDA approves Mavyret for Hepatitis C FDA OKs 8-Week Mavyret for Hepatitis C FDA approves AbbVie’s hepatitis C drug |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.